Cyclerion Therapeutics (CYCN) Long-Term Investments (2023 - 2025)
Historic Long-Term Investments for Cyclerion Therapeutics (CYCN) over the last 3 years, with Q3 2025 value amounting to $5.4 million.
- Cyclerion Therapeutics' Long-Term Investments changed 0.0% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $5.4 million for FY2024, which is 0.0% changed from last year.
- Per Cyclerion Therapeutics' latest filing, its Long-Term Investments stood at $5.4 million for Q3 2025, which was down 0.0% from $5.4 million recorded in Q2 2025.
- Cyclerion Therapeutics' 5-year Long-Term Investments high stood at $5.4 million for Q3 2023, and its period low was $5.4 million during Q3 2023.
- Its 3-year average for Long-Term Investments is $5.4 million, with a median of $5.4 million in 2023.
- Examining YoY changes over the last 5 years, Cyclerion Therapeutics' Long-Term Investments showed a top increase of 0.0% in 2024 and a maximum decrease of 0.0% in 2024.
- Over the past 3 years, Cyclerion Therapeutics' Long-Term Investments (Quarter) stood at $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025.
- Its Long-Term Investments was $5.4 million in Q3 2025, compared to $5.4 million in Q2 2025 and $5.4 million in Q1 2025.